Answer
It is not recommended in end-stage renal disease or severe hepatic impairment because it has not been studied in these groups.
Sources for this answer
- Obgemsa 75 mg film-coated tablets — Current selected SmPCemc · Summary of Product Characteristics
General medicine information. Follow the instructions for your own medicine and speak to a pharmacist or clinician about your individual circumstances.